Search results
Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune
Law.com· 3 days agoLawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...
Hims debuts $199 weight-loss shots at 85% discount to Wegovy
Detroit News· 5 days agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...
Pay for Delay Is Sometimes Okay | JD Supra
JD Supra· 2 days agoThe US Court of Appeals for the Second Circuit affirmed the dismissal of a lawsuit against pharmaceutical companies accused of violating antitrust laws by using reverse payments to delay entry ...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 5 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Zacks via Yahoo Finance· 4 days agoStiff Competition: Distribution...wholesalers, service merchandisers, self-warehousing chains,...
Viatris Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 days agoViatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As...
India's Sun Pharma beats Q4 profit view on strong US, domestic sales
Reuters via Yahoo Finance· 3 days agoIndia sales rose more than 10.2% to 37.1 billion rupees. Global speciality sales, which accounted...
Congress evaluate how to lower prescription prices by increasing competition
WPXI via Yahoo News· 4 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Does Mark Cuban still own the Mavericks? Billionaire explains why he sold NBA team to Adelson,...
Sporting News· 4 days agoMark Cuban has been a constant presence at Mavericks games throughout Dallas' playoff run, which comes as no surprise to anyone who has watched the franchise over the years. While many NBA owners ...
Hims & Hers Health says it will offer compounded GLP-1 injections
NBC Universal via AOL· 5 days agoHims & Hers CEO Andrew Dudum told CNBC that the company is “confident” that customers will be able...